Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-27

Clinical Trial Update: Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults [Phase 1]

View source ↗

Summary

A Phase 1 peanut allergy vaccine trial in healthy and peanut-allergic adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Peanut allergy vaccine

Snippet

Sponsor: Allertein Therapeutics, LLC | Conditions: Food Hypersensitivity, Hypersensitivity | Phase 1 | Status: COMPLETED